300 related articles for article (PubMed ID: 25830686)
1. Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis.
Shestivska V; Dryahina K; Nunvář J; Sovová K; Elhottová D; Nemec A; Smith D; Španěl P
J Breath Res; 2015 Apr; 9(2):027104. PubMed ID: 25830686
[TBL] [Abstract][Full Text] [Related]
2. Variability in the concentrations of volatile metabolites emitted by genotypically different strains of Pseudomonas aeruginosa.
Shestivska V; Spaněl P; Dryahina K; Sovová K; Smith D; Musílek M; Nemec A
J Appl Microbiol; 2012 Sep; 113(3):701-13. PubMed ID: 22726261
[TBL] [Abstract][Full Text] [Related]
3. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of pulmonary bacterial pathogens in cystic fibrosis by volatile metabolites emitted by their in vitro cultures: Pseudomonas aeruginosa, Staphylococcus aureus, Stenotrophomonas maltophilia and the Burkholderia cepacia complex.
Dryahina K; Sovová K; Nemec A; Španěl P
J Breath Res; 2016 Aug; 10(3):037102. PubMed ID: 27506232
[TBL] [Abstract][Full Text] [Related]
5. A rapid method for breath analysis in cystic fibrosis patients.
Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
[TBL] [Abstract][Full Text] [Related]
6. Quantification of methyl thiocyanate in the headspace of Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry.
Shestivska V; Nemec A; Dřevínek P; Sovová K; Dryahina K; Spaněl P
Rapid Commun Mass Spectrom; 2011 Sep; 25(17):2459-67. PubMed ID: 21818806
[TBL] [Abstract][Full Text] [Related]
7. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
Smith D; Španěl P
J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
[TBL] [Abstract][Full Text] [Related]
8. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D
J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768
[TBL] [Abstract][Full Text] [Related]
9. Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry.
Carroll W; Lenney W; Wang T; Spanel P; Alcock A; Smith D
Pediatr Pulmonol; 2005 May; 39(5):452-6. PubMed ID: 15765542
[TBL] [Abstract][Full Text] [Related]
10. From molecules in space to molecules in breath.
Smith D
Paediatr Respir Rev; 2016 Jan; 17():50-2. PubMed ID: 26541224
[TBL] [Abstract][Full Text] [Related]
11. Cross Platform Analysis of Volatile Organic Compounds Using Selected Ion Flow Tube and Proton-Transfer-Reaction Mass Spectrometry.
Lin GP; Vadhwana B; Belluomo I; Boshier PR; Španěl P; Hanna GB
J Am Soc Mass Spectrom; 2021 May; 32(5):1215-1223. PubMed ID: 33831301
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal study of ammonia, acetone and propanol in the exhaled breath of 30 subjects using selected ion flow tube mass spectrometry, SIFT-MS.
Turner C; Spanel P; Smith D
Physiol Meas; 2006 Apr; 27(4):321-37. PubMed ID: 16537976
[TBL] [Abstract][Full Text] [Related]
13. 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung.
Scott-Thomas AJ; Syhre M; Pattemore PK; Epton M; Laing R; Pearson J; Chambers ST
BMC Pulm Med; 2010 Nov; 10():56. PubMed ID: 21054900
[TBL] [Abstract][Full Text] [Related]
14. Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus.
Chambers ST; Bhandari S; Scott-Thomas A; Syhre M
Med Mycol; 2011 Apr; 49 Suppl 1():S54-61. PubMed ID: 20795766
[TBL] [Abstract][Full Text] [Related]
15. Repeatability of the measurement of exhaled volatile metabolites using selected ion flow tube mass spectrometry.
Boshier PR; Marczin N; Hanna GB
J Am Soc Mass Spectrom; 2010 Jun; 21(6):1070-4. PubMed ID: 20335048
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.
Filipiak W; Sponring A; Baur MM; Filipiak A; Ager C; Wiesenhofer H; Nagl M; Troppmair J; Amann A
BMC Microbiol; 2012 Jun; 12():113. PubMed ID: 22716902
[TBL] [Abstract][Full Text] [Related]
17. Pitfalls in the analysis of volatile breath biomarkers: suggested solutions and SIFT-MS quantification of single metabolites.
Smith D; Spanel P
J Breath Res; 2015 Apr; 9(2):022001. PubMed ID: 25830501
[TBL] [Abstract][Full Text] [Related]
18. Volatile molecules from bronchoalveolar lavage fluid can 'rule-in' Pseudomonas aeruginosa and 'rule-out' Staphylococcus aureus infections in cystic fibrosis patients.
Nasir M; Bean HD; Smolinska A; Rees CA; Zemanick ET; Hill JE
Sci Rep; 2018 Jan; 8(1):826. PubMed ID: 29339749
[TBL] [Abstract][Full Text] [Related]
19. Does mass spectrometric breath analysis detect Pseudomonas aeruginosa in cystic fibrosis?
Pabary R; Huang J; Kumar S; Alton EW; Bush A; Hanna GB; Davies JC
Eur Respir J; 2016 Mar; 47(3):994-7. PubMed ID: 26846826
[No Abstract] [Full Text] [Related]
20. Breath analysis for noninvasively differentiating Acinetobacter baumannii ventilator-associated pneumonia from its respiratory tract colonization of ventilated patients.
Gao J; Zou Y; Wang Y; Wang F; Lang L; Wang P; Zhou Y; Ying K
J Breath Res; 2016 Jun; 10(2):027102. PubMed ID: 27272697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
